Why the study?
Does platelet angiotensin II binding predict the development of pre-eclampsia in women with pregnancy-induced hypertension?
Does platelet angiotensin II binding predict the development of pre-eclampsia in women with pregnancy-induced hypertension?
Platelet angiotensin II binding measured at admission for non-proteinuric pregnancy-induced hypertension may serve as a prognostic indicator for the onset of pre-eclampsia.
Answers are grounded in this paper and cite their sources.
May support prognostic use in pregnancy-induced hypertension; leaves open validation in prospective cohorts before clinical adoption.
This was a preliminary investigation to assess the value of platelet angiotensin II binding as a prognostic indicator for subsequent pre-eclampsia in women admitted with non-proteinuric pregnancy-induced hypertension. Platelet angiotensin II binding was measured in 26 women at the onset of their symptoms. All were primparous, had singleton pregnancies, were normotensive at booking and had an unremarkable medical history. The blood pressure of seven women resolved and returned to normal; 11 women remained stable throughout the remainder of their pregnancy, their blood pressure remained elevated but they did not develop significant proteinuria. Eight women developed pre-eclampsia. Platelet angiotensin II binding in the pre-eclamptic group was significantly higher compared to those who remained stable (P = 0.042) or those whose condition improved (P = 0.021). We conclude that angiotensin II binding measured at the time of admission to hospital for non-proteinuric pregnancy-induced hypertension may have a role in predicting the onset of pre-eclampsia or eclampsia.
No takes yet. Share an insight, caveat, or question.
Tracy J. Walker P. M. S. O'Brien (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: